Tulobuterol is a long-acting, inhaled beta2 agonist used as a bronchodilator to treat chronic obstructive pulmonary disease (COPD). It is a selective agonist of the β2-adrenergic receptor, which works to relax the smooth muscles of the airways, allowing increased airflow. It is particularly useful in people who suffer from frequent or severe exacerbations. Tulobuterol is available in both dry powder and solution formulations. The most common side effects include headache, dry mouth, cough, and throat irritation.
Tilobuerol is a long-acting beta2-adrenergic receptor agonist medication used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, which helps to open up the airways and make breathing easier.
Tilobuerol is most commonly available as a transdermal patch, applied to the skin. This patch delivers a steady stream of medication into the bloodstream over a 24-hour period.
Tilobuerol is not available in the United States or many other Western countries. It is currently only legal in a handful of countries, including Japan, Germany, China, and India.